Halo Collective Inc. (HCANF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Halo Collective Inc. (HCANF) trades at $0.00 with AI Score 42/100 (Grade C). Halo Collective Inc. is a vertically integrated cannabis company engaged in cultivation, manufacturing, and distribution of cannabis products across the United States. Market cap: $15,081, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for HCANF: HCANF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HCANF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HCANF: the 1 perspectives are evenly split.
How is this calculated? →Halo Collective Inc. (HCANF) Healthcare & Pipeline Overview
Halo Collective Inc. is a vertically integrated cannabis company founded in 2016, specializing in the cultivation, manufacturing, and distribution of cannabis products across the United States. Operating under brands like Hush and Mojave, it offers flowers, oils, concentrates, and edibles to licensed retailers and wholesalers, navigating the evolving cannabis market.
What Is the Investment Thesis for HCANF?
Halo Collective Inc. presents an investment profile centered on its vertically integrated cannabis operations across the United States, particularly in California and Oregon. The company's strategy involves controlling the entire value chain from cultivation to manufacturing and distribution, which can offer operational efficiencies and quality consistency. Its diversified product portfolio, encompassing flowers, oils, concentrates, and edibles under established brands like Hush, Mojave, and Exhale, caters to varied consumer preferences and market segments. Strategic partnerships with entities such as High Tide Inc. and OG DNA Genetics Inc. are key growth catalysts, potentially expanding market reach and enhancing product innovation through genetic development. However, investors must consider the company's financial metrics, including a significant negative profit margin of -341.8% and a gross margin of 21.1%, indicating ongoing challenges in achieving profitability. The high beta of 4.18 suggests substantial price volatility, typical of emerging sectors and smaller market capitalization companies. Its listing on the OTC Other tier also implies a higher risk profile due to potentially lower transparency and liquidity. The thesis for Halo Collective hinges on its ability to leverage its operational infrastructure and partnerships to navigate the complex and evolving regulatory landscape of the cannabis industry, improve its financial performance, and demonstrate a clear path towards sustainable profitability and market share expansion.
Based on FMP financials and quantitative analysis
HCANF Key Highlights
- Market capitalization is $0.00 billion, reflecting a micro-cap valuation.
- Reported a profit margin of -341.8%, indicating significant unprofitability in its operations.
- Achieved a gross margin of 21.1%, demonstrating some efficiency in its cost of goods sold.
- Exhibits a high beta of 4.18, suggesting substantial price volatility relative to the broader market.
- Manages a workforce of 114 employees, supporting its vertically integrated cannabis operations.
Who Are HCANF's Competitors?
HCANF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HCANF's Key Strengths?
- Vertically integrated operations from cultivation to distribution.
- Diversified product portfolio including flowers, oils, concentrates, and edibles.
- Established proprietary brands such as Hush, Mojave, and Exhale.
- Strategic partnerships with High Tide Inc. and OG DNA Genetics Inc.
- Presence in key U.S. cannabis markets (California, Oregon).
What Are HCANF's Weaknesses?
- Significant negative profit margin (-341.8%).
- Listing on the OTC Other tier, implying higher risk and lower transparency.
- High beta (4.18) indicating substantial price volatility.
- Need to achieve sustainable profitability.
What Could Drive HCANF Stock Higher?
- Strategic partnership with High Tide Inc. potentially expanding retail reach and market access for Halo Collective's products.
- Alliance with OG DNA Genetics Inc. focused on developing advanced cannabis genetics in Oregon, enhancing product innovation and differentiation.
- Potential for increased market penetration and sales growth for its branded products (Hush, Mojave, Exhale) in California and Oregon.
- Efforts to improve operational efficiencies across its vertically integrated supply chain, aiming to enhance gross margins and profitability.
- Strategic initiatives to expand product availability or introduce new cannabis product forms in existing or new legal markets.
What Are the Key Risks for HCANF?
- Financial-distress signal — its Altman Z-Score of -13.50 sits in the distress zone (elevated bankruptcy risk).
- Significant negative profit margin of -341.8%, indicating substantial unprofitability that requires ongoing capital.
- Listing on the OTC Other tier, which carries inherent risks of lower transparency, reduced liquidity, and increased price volatility.
- The highly dynamic and fragmented regulatory landscape of the U.S. cannabis industry poses ongoing compliance and operational challenges.
- Intense competition from numerous established and emerging cannabis companies could pressure pricing and market share.
- High beta of 4.18 suggests that the stock price is significantly more volatile than the broader market, increasing investment risk.
What Are the Growth Opportunities for HCANF?
- Expansion of Branded Product Portfolio and Market Penetration: Halo Collective Inc. has established brands such as Hush, Mojave, and Exhale, alongside a diverse product range including flowers, oils, concentrates, gummies, and syrup beverages. A significant growth opportunity lies in expanding the availability and market share of these branded products within its existing operational states of California and Oregon, and potentially into new legal markets as regulations evolve. By enhancing brand recognition and distribution networks, the company can capitalize on increasing consumer demand for differentiated and trusted cannabis products, driving higher sales volumes and potentially improving gross margins. This strategy aims to capture a larger segment of the growing legal cannabis market, which continues to see strong consumer adoption.
- Leveraging Strategic Partnerships for Innovation and Reach: The company's alliance with OG DNA Genetics Inc. for cannabis genetics development in Oregon presents a crucial opportunity for product innovation and differentiation. Developing proprietary or superior cannabis strains can provide a competitive edge, leading to higher-quality products and potentially premium pricing. Furthermore, the strategic partnership with High Tide Inc. offers avenues for expanded retail distribution and market access, particularly in regions where High Tide has a strong presence. These collaborations can accelerate product development cycles, optimize cultivation practices, and broaden the company's customer base, contributing to long-term revenue growth and market relevance.
- Geographic Expansion into New Legal Cannabis Markets: While currently focused on California and Oregon, the ongoing trend of cannabis legalization across more U.S. states presents a substantial growth opportunity for Halo Collective Inc. As more states establish regulated cannabis markets, the company could strategically expand its cultivation, manufacturing, and distribution operations into these new territories. Such expansion would require careful navigation of diverse state-specific regulatory frameworks and significant capital investment, but it would unlock access to larger consumer populations and diversify revenue streams beyond its current core markets, positioning the company for broader national presence in the burgeoning cannabis industry.
- Optimization of Vertical Integration for Cost Efficiencies: Halo Collective's vertically integrated model, encompassing cultivation, manufacturing, and distribution, offers inherent opportunities for operational optimization and cost reduction. By refining processes across its supply chain, from improving cultivation yields and reducing waste to streamlining extraction and manufacturing, the company can enhance its gross margins and move towards profitability. Investing in advanced agricultural technologies, automation in processing, and efficient logistics can significantly lower the cost of goods sold. This internal efficiency drive is critical for a company with a negative profit margin, allowing it to become more competitive on pricing while improving its financial health in the long term.
- Innovation in Edibles and Alternative Consumption Methods: The market for cannabis edibles and alternative consumption methods, such as beverages and tinctures, is experiencing rapid growth and consumer acceptance. Halo Collective Inc. already offers cannabis-infused gummies and a syrup beverage in California and Oregon. Expanding this product line with new flavors, formulations, and innovative delivery methods represents a significant growth opportunity. Developing novel edible products that cater to specific consumer preferences for dosage, onset time, and experience can attract new customer segments and increase market share in this high-growth category, diversifying revenue away from traditional flower products and potentially commanding higher margins.
What Opportunities Does HCANF Have?
- Expansion into new legal cannabis markets within the U.S.
- Leveraging strategic partnerships for enhanced product innovation and market reach.
- Growth in demand for cannabis edibles and alternative consumption methods.
- Operational efficiencies through optimization of vertical integration.
What Threats Does HCANF Face?
- Complex and evolving regulatory landscape in the cannabis industry.
- Intense competition from numerous established and emerging cannabis operators.
- Challenges in securing capital for expansion and operations.
- Potential for market saturation and pricing pressures.
What Are HCANF's Competitive Advantages?
- Vertical Integration: Controls the entire process from cultivation to manufacturing and distribution, ensuring quality and potentially reducing costs.
- Diversified Product Portfolio: Offers a broad range of products including flowers, oils, concentrates, and edibles, catering to diverse consumer preferences.
- Established Brand Portfolio: Owns recognized brands such as Hush, Mojave, and Exhale, which can foster customer loyalty and market presence.
- Strategic Partnerships: Collaborations with High Tide Inc. and OG DNA Genetics Inc. provide enhanced market access and specialized genetic development capabilities.
- Multi-State Operations: Established presence in key U.S. cannabis markets like California and Oregon, offering a foundation for further expansion.
What Does HCANF Do?
Founded in 2016 and headquartered in Toronto, Canada, Halo Collective Inc. operates as a vertically integrated cannabis company with a comprehensive presence across the United States. The firm, which adopted its current name in January 2021 after previously operating as Halo Labs Inc., focuses on the entire cannabis value chain. Its core operations encompass the cultivation of cannabis plants, advanced extraction processes to derive cannabis oils and concentrates, and the manufacturing of a diverse range of cannabis products. This vertical integration allows Halo Collective to maintain quality control and efficiency from seed to sale. The company's product portfolio is extensive, featuring traditional cannabis flowers, various forms of oils, and high-potency concentrates. Expanding beyond these core offerings, Halo Collective also produces a selection of edible products, including cannabis-infused gummies and a unique syrup beverage, which are specifically available in the California and Oregon markets. These products cater to a broad consumer base seeking different consumption methods and experiences. Halo Collective Inc. strategically markets both its proprietary branded products and private label items. Its own established brands, such as Hush, Mojave, and Exhale, are recognized in the cannabis retail space. The company primarily distributes its cannabis offerings to licensed dispensaries, serving a clientele that includes both licensed retailers and wholesalers. Furthermore, Halo Collective has forged significant strategic collaborations, notably a partnership with High Tide Inc., a prominent retail-focused cannabis company, and an alliance with OG DNA Genetics Inc., specifically aimed at developing advanced cannabis genetics within Oregon. These partnerships are designed to enhance its market reach, product innovation, and genetic capabilities, reinforcing its position within the dynamic and competitive cannabis industry.
What Products and Services Does HCANF Offer?
- Cultivates cannabis plants for various product forms.
- Extracts and processes cannabis into oils and concentrates.
- Manufactures a range of cannabis products, including flowers, oils, and concentrates.
- Produces edible cannabis products such as gummies and syrup beverages.
- Develops and markets its own cannabis brands like Hush, Mojave, and Exhale.
- Offers private label cannabis products to clients.
- Distributes cannabis products primarily to licensed dispensaries, retailers, and wholesalers.
- Engages in strategic partnerships for retail expansion and cannabis genetics development.
How Does HCANF Make Money?
- Generates revenue through the cultivation, manufacturing, and distribution of branded and private label cannabis products.
- Sells a diverse portfolio including cannabis flowers, oils, concentrates, and edibles to licensed B2B clients.
- Operates a vertically integrated model to control quality and efficiency across the cannabis supply chain.
- Leverages strategic partnerships to enhance product development and market reach in key U.S. states.
What Industry Does HCANF Operate In?
Halo Collective Inc. operates within the rapidly evolving and highly competitive cannabis sector, specifically as a drug manufacturer specializing in specialty and generic cannabis products. The industry is characterized by a complex patchwork of state-level regulations in the United States, driving a dynamic market landscape. Halo Collective's vertically integrated model positions it to capture value across cultivation, manufacturing, and distribution, a strategy common among larger cannabis enterprises seeking efficiency and quality control. The market is experiencing significant growth driven by increasing legalization and consumer acceptance, but also faces challenges from illicit markets, high taxation, and capital constraints. Halo Collective competes with numerous licensed cultivators, processors, and distributors. Its focus on both branded products (Hush, Mojave, Exhale) and private label offerings allows it to address different market segments, while its strategic alliances aim to enhance its competitive standing in key markets like California and Oregon.
Who Are HCANF's Key Customers?
- Licensed cannabis dispensaries.
- Licensed cannabis retailers.
- Cannabis wholesalers.
Company Profile
Halo Collective Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Marshall Minor. HCANF has traded publicly since 2010.
Halo Collective Inc. (HCANF) Valuation Context
Valued at 15K, HCANF is classified as a micro-cap stock. Relative to its peer group, HCANF's quantitative score of 42/100 is below the peer average of 66/100.
F-Score 4/9Financial Health
Halo Collective Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -13.50 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Halo Collective Inc. revenue of about $44.1M for fiscal 2026, with EPS near $-99.24.
HCANF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations from cultivation to distribution.
- Diversified product portfolio including flowers, oils, concentrates, and edibles.
- Established proprietary brands such as Hush, Mojave, and Exhale.
- Strategic partnerships with High Tide Inc. and OG DNA Genetics Inc.
Bear Case
- Significant negative profit margin (-341.8%).
- Listing on the OTC Other tier, implying higher risk and lower transparency.
- High beta (4.18) indicating substantial price volatility.
- Need to achieve sustainable profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
HCANF Latest News
No recent news available for HCANF.
HCANF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HCANF.
Price Targets
Wall Street price target analysis for HCANF.
HCANF MoonshotScore
What does this score mean?
The MoonshotScore rates HCANF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Marshall Minor
Chief Executive Officer
Unknown. Information regarding Marshall Minor's specific career history, educational background, and previous roles prior to leading Halo Collective Inc. is not provided in the source data.
Track Record: Unknown. Details on key achievements, strategic decisions, or specific company milestones directly attributable to Marshall Minor's leadership at Halo Collective Inc. are not available in the provided information.
HCANF OTC Market Information
Halo Collective Inc.'s listing on the OTC Other tier signifies that it trades on the over-the-counter market, distinct from major exchanges like the NYSE or NASDAQ. Companies on the OTC Other tier typically have minimal public disclosure requirements, often providing less financial and operational transparency compared to those on higher OTC tiers or national exchanges. This tier is generally associated with micro-cap, distressed, or speculative companies, and it implies a higher risk profile for investors due to less stringent reporting standards and potentially less oversight, making comprehensive due diligence more challenging for institutional investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public disclosure and transparency compared to major exchanges.
- Lower liquidity, potentially leading to wider bid-ask spreads and difficulty in trading.
- Increased price volatility due to smaller market capitalization and less institutional interest.
- Higher susceptibility to market manipulation and speculative trading.
- Potential for delisting or further restrictions if disclosure standards are not met.
- Verify any available financial statements and regulatory filings, if disclosed.
- Research the background and track record of the management team.
- Assess the company's operational assets and revenue generation capabilities.
- Evaluate the competitive landscape and regulatory compliance within its sector.
- Analyze trading volume and historical price movements for liquidity insights.
- Seek independent third-party reports or analyses, if available.
- Active operations as a vertically integrated cannabis company.
- Established headquarters in Toronto, Canada.
- Proprietary brands (Hush, Mojave, Exhale) and diversified product lines.
- Strategic partnerships with High Tide Inc. and OG DNA Genetics Inc.
- Identifiable employee count (114 employees).
Common Questions About HCANF (Healthcare)
What is Halo Collective Inc.'s primary business model in the cannabis sector?
Halo Collective Inc. operates as a vertically integrated cannabis company, meaning it manages the entire supply chain from cultivation and extraction to manufacturing and distribution. Its core business involves growing cannabis, processing it into various forms like oils and concentrates, and producing finished products such as flowers, edibles (gummies, syrup beverages), and concentrates. The company markets both its own proprietary brands, including Hush, Mojave, and Exhale, and private label items. These products are primarily sold to licensed dispensaries, retailers, and wholesalers across the United States, with a notable presence in California and Oregon. This model aims to ensure quality control and capture value at multiple stages of the cannabis value chain.
How does Halo Collective Inc. address the competitive and regulatory landscape in the cannabis industry?
Halo Collective Inc. navigates the competitive cannabis landscape through its vertically integrated operations, diversified product portfolio, and established brands like Hush, Mojave, and Exhale, which aim to build consumer loyalty. To address market dynamics and enhance its position, the company has formed strategic partnerships, such as with High Tide Inc. for potential market expansion and with OG DNA Genetics Inc. for developing advanced cannabis genetics in Oregon. Regarding the complex regulatory environment, the company operates within the legal frameworks of states like California and Oregon. However, the evolving nature of cannabis regulations across the U.S. remains an ongoing challenge, requiring continuous adaptation and compliance efforts to maintain its operational licenses and market access.
What are the financial characteristics and risks associated with investing in HCANF, particularly as an OTC-listed company?
Halo Collective Inc. exhibits specific financial characteristics and risks. Financially, the company currently reports a significant negative profit margin of -341.8% and a gross margin of 21.1%, indicating challenges in achieving profitability. Its beta of 4.18 suggests high volatility, meaning its stock price tends to fluctuate more dramatically than the overall market. As an OTC-listed company on the "OTC Other" tier, HCANF faces additional risks. This tier typically implies lower disclosure requirements, which can lead to reduced transparency for investors. Furthermore, OTC stocks often experience lower trading volumes and wider bid-ask spreads, resulting in decreased liquidity and potential difficulties in executing trades efficiently.
What are the key factors to evaluate for HCANF?
Halo Collective Inc. (HCANF) holds an AI score of 42/100 (low). Not financial advice.
How frequently does HCANF data refresh on this page?
HCANF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HCANF's recent stock price performance?
Halo Collective Inc. (HCANF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations from cultivation to distribution. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HCANF overvalued or undervalued right now?
Valuing Halo Collective Inc. (HCANF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HCANF?
Before investing in Halo Collective Inc. (HCANF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information derived from provided source data. No external information used.